Proposals to restrict access to ketamine by making it a "Schedule I" drug would have a major impact on the availability of anesthesia and surgery in low- to middle-income countries (LMICs)—where ketamine is often the only general anesthetic drug available, according to experts.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1V15ghI
No comments:
Post a Comment